表 1.
两组患者的基线资料比较
Clinical characteristics of the patients in the modeling group and validation group
| Variable | Modeling group(D) n=856 | Validation group(V) n=285 | P |
| SBP: Systolic blood pressure; DBP: diastolic blood pressure; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; NC: Neck circumference; HC: Hip circumference; RBC: Red blood Cells; WBC: White blood cells; RDW: Red cell distribution width; PLT: Platelet; MCHC: mean corpuscular hemoglobin contentration; PDW: Platelet distribution width; LAT: The longest apnea time; rGT: Gammaglutamyl transpeptidase; AST: Glutamic oxalacetic transaminase; ALT: Glutamic-pyruvic transaminas; RDW: Red cell distribution width; MCV: Mean red cell volume; MCHC: mean red cell hemoglobin concentration; MPV: Mean platelet volume; PDW: Platelet distribution width; PLT: Platelet; BNP: B-type natriuretic peptides; CRP: C- reactive protein; AO: Ascending aorta; PO: Pulmonary artery; RPO: Right pulmonary artery; LV: Left ventricular; LA: Left atrium; RV: Right ventricle. | |||
| Age [year, M(Q1, Q3)] | 66.00(62.00, 71.00) | 66.00(63.00, 71.00) | 0.422 |
| Male [n(%)] | 527 (61.57) | 171 (60.00) | 0.639 |
| Smoking [n(%)] | 125 (14.60) | 45 (15.79) | 0.599 |
| Drinking [n(%)] | 86 (9.96) | 23 (8.56) | 0.601 |
| BMI [kg/m2, M(Q1, Q3)] | 26.33(23.90, 29.07) | 26.57(23.88, 28.73) | 0.909 |
| SBP [mmHg, M(Q1, Q3)] | 130.00 (124.00, 142.00) | 130.00 (120.00, 145.00) | 0.741 |
| DBP [mmHg, M(Q1, Q3)] | 76.00(70.00, 82.00) | 76.00(70.00, 81.00) | 0.618 |
| WC [cm, M(Q1, Q3)] | 90.00 (80.00, 100.00) | 89.00(80.00, 99.00) | 0.895 |
| HC [cm, M(Q1, Q3)] | 102.00(96.00, 107.00) | 100.00(96.00, 107.00) | 0.387 |
| NC [cm, M(Q1, Q3)] | 38.00(35.00, 40.00) | 38.00(36.00, 40.00) | 0.819 |
| AHI [events/h, M(Q1, Q3)] | 27.85(15.28, 46.82) | 24.70(13.50, 44.20) | 0.115 |
| TST [h, M(Q1, Q3)] | 7.05(6.15, 7.47) | 7.00(6.10, 7.40) | 0.648 |
| ODI [events/h, M(Q1, Q3)] | 22.40(10.67, 40.92) | 20.10(9.90, 39.80) | 0.449 |
| TSA90[min, M(Q1, Q3)] | 15.00(2.40, 65.65) | 10.70(1.94, 43.11) | 0.052 |
| MAT [s, M(Q1, Q3)] | 22.57(19.60, 25.61) | 21.51(18.60, 24.69) | 0.008 |
| LAT [s, M(Q1, Q3)] | 52.00(33.00, 76.00) | 48.80(31.00, 73.00) | 0.162 |
| MSpO2 [%, M(Q1, Q3)] | 93.00(91.47, 95.00) | 94.00(92.00, 95.00) | 0.312 |
| Average heart rate [events/h, M(Q1, Q3)] | 63.00(57.58, 68.00) | 64.00(58.00, 69.00) | 0.213 |
| LSpO2 [%, M(Q1, Q3)] | 80.00(72.00, 85.00) | 80.00(73.00, 85.00) | 0.659 |
| Total bilirubin[μmol/L, M(Q1, Q3)] | 10.50(8.00, 14.03) | 10.40(8.10, 14.20) | 0.852 |
| Indirect bilirubin[μmol/L, M(Q1, Q3)] | 8.40(6.40, 10.41) | 8.30(6.20, 10.16) | 0.213 |
| Direct bilirubin[μmol/L, M(Q1, Q3)] | 3.60(2.90, 4.90) | 3.60(2.90, 5.10) | 0.776 |
| TC [mmol/L, M(Q1, Q3)] | 4.23(3.55, 4.94) | 4.28(3.59, 5.00) | 0.524 |
| TG [μmol/L, M(Q1, Q3)] | 1.36(1.01, 1.90) | 1.38(0.99, 1.90) | 0.967 |
| HDL[μmol/L, M(Q1, Q3)] | 1.07(0.89, 1.33) | 1.13(0.89, 1.42) | 0.065 |
| LDL[μmol/L, M(Q1, Q3)] | 2.44(1.89, 3.02) | 2.45(1.88, 3.02) | 0.931 |
| rGT [U/L, M(Q1, Q3)] | 27.10(19.90, 37.40) | 27.60(19.80, 33.00) | 0.739 |
| ALT [U/L, M(Q1, Q3)] | 16.85(12.10, 26.18) | 17.70(12.60, 26.40) | 0.309 |
| AST [U/L, M(Q1, Q3)] | 17.50(14.45, 23.00) | 17.50(14.10, 23.00) | 0.971 |
| Creatinine[μmol/L, M(Q1, Q3)] | 72.68(62.60, 83.75) | 72.91(61.00, 85.00) | 0.958 |
| Urea[μmol/L, M(Q1, Q3)] | 6.20(5.00, 8.90) | 6.10(5.00, 8.80) | 0.891 |
| Uric acid[μmol/L, M(Q1, Q3)] | 346.90(306.52, 391.25) | 342.00 (288.40, 390.60) | 0.306 |
| FPG [mmol/L, M(Q1, Q3)] | 5.70(5.04, 6.51) | 5.66(5.14, 6.60) | 0.518 |
| BNP [pg/mL, M(Q1, Q3)] | 96.95 (45.80, 328.42) | 123.40(47.40, 607.67) | 0.243 |
| CRP [mg/L, M(Q1, Q3)] | 0.96(0.31, 4.68) | 0.78(0.30, 3.65) | 0.679 |
| RDW [rf, M(Q1, Q3)] | 12.90(12.50, 13.20) | 12.90(12.50, 13.30) | 0.225 |
| MCV [rf, M(Q1, Q3)] | 90.80(88.20, 94.03) | 90.70(87.60, 94.10) | 0.415 |
| MCHC [g/L, M(Q1, Q3)] | 336.00 (328.00, 344.00) | 336.71 (329.00, 343.00) | 0.876 |
| PLT [109/L, M(Q1, Q3)] | 202.00 (170.00, 238.12) | 204.00 (172.33, 236.00) | 0.665 |
| MPV [rf, M(Q1, Q3)] | 10.40(9.70, 11.20) | 10.30(9.80, 11.10) | 0.822 |
| PDW [%, M(Q1, Q3)] | 12.70(11.00, 13.90) | 12.70(11.00, 13.80) | 0.412 |
| RBC [1012/L, M(Q1, Q3)] | 4.50(4.19, 4.82) | 4.47(4.18, 4.83) | 0.681 |
| WBC [109/L, M(Q1, Q3)] | 6.28(5.29, 7.30) | 6.20(5.21, 7.16) | 0.546 |
| Neutrophil [%, M(Q1, Q3)] | 61.54(55.00, 67.43) | 61.70(53.70, 67.50) | 0.626 |
| Hemoglobin[g/L, M(Q1, Q3)] | 138.50 (129.00, 147.00) | 138.00 (127.00, 147.00) | 0.428 |
| Eosinophils [%, M(Q1, Q3)] | 2.07(1.30, 3.20) | 2.30(1.28, 3.50) | 0.101 |
| Internal diameter of AO [mm, M(Q1, Q3)] | 33.00(30.00, 35.18) | 32.50(30.00, 36.00) | 0.637 |
| Internal diameter of PO [mm, M(Q1, Q3)] | 23.40(21.00, 25.00) | 23.00(21.05, 25.00) | 0.498 |
| Internal diameter of RPO [mm, M(Q1, Q3)] | 13.50(11.00, 16.00) | 13.00(11.00, 16.00) | 0.524 |
| LV diameter [mm, M(Q1, Q3)] | 47.00(44.00, 50.00) | 47.00(42.00, 49.00) | 0.296 |
| LVEF [%, M(Q1, Q3)] | 64.00(60.00, 68.00) | 63.12(60.00, 68.99) | 0.765 |
| Anteroposterior diameter of LA [mm, M(Q1, Q3)] | 36.00(33.00, 40.00) | 35.10(32.30, 39.92) | 0.342 |
| Left and right diameter of RV [mm, M(Q1, Q3)] | 31.00(28.00, 35.00) | 32.00(28.00, 35.00) | 0.666 |
| Homocysteine [mol/L, M(Q1, Q3)] | 13.80(10.80, 18.20) | 13.70(10.00, 18.30) | 0.729 |
| CystatinC [mg/L, M(Q1, Q3)] | 0.96(0.81, 1.13) | 0.93(0.78, 1.10) | 0.146 |
| Hypertension[n(%)] | 540 (63.08) | 186 (65.26) | 0.508 |
| Carotid atherosclerosis [n(%)] | 223 (26.05) | 66 (23.16) | 0.331 |
| CHD [n(%)] | 206 (24.31) | 55 (22.69) | 0.212 |
| Hyperlipidemia [n(%)] | 230 (26.87) | 84 (29.47) | 0.394 |
| Diabetes [n(%)] | 197 (23.01) | 77 (27.02) | 0.171 |
| COPD [n(%)] | 57 (6.66) | 22 (7.72) | 0.541 |
| Peptic Ulcer [n(%)] | 15 (1.75) | 3 (1.05) | 0.412 |
| Atrial fibrillation[n (%)] | 65 (7.59) | 30 (10.53) | 0.121 |
| Follow-up [months, M(Q1, Q3)] | 43（41, 54） | 42（41, 54） | 0.853 |